Abstract

BackgroundNicotinamide adenine dinucleotide phosphate (NADPH) is an important cofactor ensuring intracellular redox balance, anabolism and cell growth in all living systems. Our recent multi-omics analyses of glucoamylase (GlaA) biosynthesis in the filamentous fungal cell factory Aspergillus niger indicated that low availability of NADPH might be a limiting factor for GlaA overproduction.ResultsWe thus employed the Design-Build-Test-Learn cycle for metabolic engineering to identify and prioritize effective cofactor engineering strategies for GlaA overproduction. Based on available metabolomics and 13C metabolic flux analysis data, we individually overexpressed seven predicted genes encoding NADPH generation enzymes under the control of the Tet-on gene switch in two A. niger recipient strains, one carrying a single and one carrying seven glaA gene copies, respectively, to test their individual effects on GlaA and total protein overproduction. Both strains were selected to understand if a strong pull towards glaA biosynthesis (seven gene copies) mandates a higher NADPH supply compared to the native condition (one gene copy). Detailed analysis of all 14 strains cultivated in shake flask cultures uncovered that overexpression of the gsdA gene (glucose 6-phosphate dehydrogenase), gndA gene (6-phosphogluconate dehydrogenase) and maeA gene (NADP-dependent malic enzyme) supported GlaA production on a subtle (10%) but significant level in the background strain carrying seven glaA gene copies. We thus performed maltose-limited chemostat cultures combining metabolome analysis for these three isolates to characterize metabolic-level fluctuations caused by cofactor engineering. In these cultures, overexpression of either the gndA or maeA gene increased the intracellular NADPH pool by 45% and 66%, and the yield of GlaA by 65% and 30%, respectively. In contrast, overexpression of the gsdA gene had a negative effect on both total protein and glucoamylase production.ConclusionsThis data suggests for the first time that increased NADPH availability can indeed underpin protein and especially GlaA production in strains where a strong pull towards GlaA biosynthesis exists. This data also indicates that the highest impact on GlaA production can be engineered on a genetic level by increasing the flux through the pentose phosphate pathway (gndA gene) followed by engineering the flux through the reverse TCA cycle (maeA gene). We thus propose that NADPH cofactor engineering is indeed a valid strategy for metabolic engineering of A. niger to improve GlaA production, a strategy which is certainly also applicable to the rational design of other microbial cell factories.

Highlights

  • Nicotinamide adenine dinucleotide phosphate (NADPH) is an important cofactor ensuring intracel‐ lular redox balance, anabolism and cell growth in all living systems

  • Strain generation using CRISPR/Cas9 technology and the synthetic Tet‐on gene switch In order to compare the effect of the seven selected genes on GlaA production in an A. niger strain carrying one glaA (AB4.1) or seven glaA (B36) gene copies, we first had to ensure that the introduced genetic modifications would allow us to directly compare the observed phenotypes

  • This study demonstrates that the NADPH pool can be increased by

Read more

Summary

Introduction

Nicotinamide adenine dinucleotide phosphate (NADPH) is an important cofactor ensuring intracel‐ lular redox balance, anabolism and cell growth in all living systems. Our recent multi-omics analyses of glucoamylase (GlaA) biosynthesis in the filamentous fungal cell factory Aspergillus niger indicated that low availability of NADPH might be a limiting factor for GlaA overproduction. The filamentous fungus Aspergillus niger is one of the main cell factories used nowadays in the industry for homologous or heterologous protein production due to its extraordinary ability for protein expression and secretion [1,2,3]. For the cell factory A. niger, several genetic approaches have proven their potency to improve its enzyme producing capability, including protein carrier approaches, tunable Tet-on driven gene expression, and morphology engineering, to name but a few [1, 7,8,9]. CspA1-, pyrG − cspA1-, pyrG + Multi copies of glaA, amdS + pyrG-, with 195 bp deletion at 101 bp ~ 295 bp after pyrG start codon Overexpression of An02g12140 (gsdA) via Tet-on, pyrG + Overexpression of An02g12140 (gsdA) via Tet-on, pyrG + Overexpression of An11g02040 (gndA) via Tet-on, pyrG + Overexpression of An11g02040 (gndA) via Tet-on, pyrG + Overexpression of An02g12430 (icdA) via Tet-on, pyrG + Overexpression of An02g12430 (icdA) via Tet-on, pyrG + Overexpression of An05g00930 (maeA) via Tet-on, pyrG + Overexpression of An05g00930 (maeA) via Tet-on, pyrG + Overexpression of An14g00430 via Tet-on, pyrG + Overexpression of An14g00430 via Tet-on, pyrG +

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.